NCT05191940 2026-03-20
LAPC
EBG MedAustron GmbH
Phase NA Recruiting
Clinical Trials
14 trialsNCT06889844 2025-10-01
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
ADVANCED MARKER DISCOVERY S.L.
Recruiting
NCT06605404 2025-08-14
Pan-tumor MRD Study
Paradigm Health
Recruiting
NCT05854368 2025-05-16
PREGASIGN#1
Institut Pasteur
Phase NA Recruiting
NCT06703632 2025-02-27
MS-Prevecol
ADVANCED MARKER DISCOVERY S.L.
Phase NA Recruiting
NCT06738511 2024-12-17
Validation of a Molecular Signature for Early Detection of Colorectal Cancer
ADVANCED MARKER DISCOVERY S.L.
Phase NA Completed
NCT04264754 2021-05-06
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Nucleix Ltd.
Terminated
NCT03706235 2020-07-14
NOVA
Clinical Genomics Pathology
Completed
NCT03706248 2020-02-13
PASCAL
Clinical Genomics Pathology
Completed
NCT01521780 2015-11-02
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT00855348 2014-08-04
PRESEPT
Epigenomics, Inc
Completed
NCT01329718 2014-08-04
SPR0012
Epigenomics, Inc
Phase EARLY_PHASE1 Completed
NCT01209013 2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3 Withdrawn
NCT00140036 2008-03-03
Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
Pfizer
Phase 4 Completed